Peng, M., Huang, Y., Tao, T., Peng, C., Su, Q., Xu, W., . . . Yang, X. (2016). Metformin and gefitinib cooperate to inhibit bladder cancer growth via both AMPK and EGFR pathways joining at Akt and Erk. Sci Rep.

Peng, Mei, Yanjun Huang, Ting Tao, Cai-Yun Peng, Qiongli Su, Wanjun Xu, Kwame Oteng Darko, Xiaojun Tao, und Xiaoping Yang. "Metformin and Gefitinib Cooperate to Inhibit Bladder Cancer Growth Via Both AMPK and EGFR Pathways Joining At Akt and Erk." Sci Rep 2016.

Peng, Mei, et al. "Metformin and Gefitinib Cooperate to Inhibit Bladder Cancer Growth Via Both AMPK and EGFR Pathways Joining At Akt and Erk." Sci Rep 2016.